Journal
NATURE REVIEWS CLINICAL ONCOLOGY
Volume 8, Issue 9, Pages 511-512Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrclinonc.2011.123
Keywords
-
Categories
Ask authors/readers for more resources
Three recent population studies have translated laboratory investigations into a clinical setting and concur in presenting evidence that suggest a dramatic new role for beta-blockers in reducing metastases, tumor recurrence and specific mortality in breast cancer. Should we be skeptical about these controversial findings?
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
